Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Ritz

Showing results (301-310 of 334) with videos related to

Pageof 34
Sort By:
Journal of the American Society of Nephrology : JASN|December 31, 2005
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease studyEva Boes, Danilo Fliser, Eberhard Ritz, et al.
Cardiovascular Research|February 16, 2012
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular diseaseAndreas Tomaschitz, Eberhard Ritz, Burkert Pieske, et al.
Circulation|August 25, 2010
Homoarginine, cardiovascular risk, and mortalityWinfried März, Andreas Meinitzer, Christiane Drechsler, et al.
Kidney International|March 23, 2012
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockersHiddo J Lambers Heerspink, Frank A Holtkamp, Hans-Henrik Parving, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2011
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysisWinfried März, Bernd Genser, Christiane Drechsler, et al.
European Heart Journal|August 7, 2010
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patientsChristiane Drechsler, Stefan Pilz, Barbara Obermayer-Pietsch, et al.
European Heart Journal|December 6, 2012
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patientsChristiane Drechsler, Eberhard Ritz, Andreas Tomaschitz, et al.
Kidney & Blood Pressure Research|August 19, 2004
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristicsChristoph Wanner, Vera Krane, Winfried März, et al.
The New England Journal of Medicine|March 11, 2011
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesHermann Haller, Sadayoshi Ito, Joseph L Izzo, et al.
Journal of Hypertension|April 13, 2004
High prevalence and poor control of hypertension in primary care: cross-sectional studyArya M Sharma, Hans-Ulrich Wittchen, Wilhelm Kirch, et al.
Pageof 34

Showing results (301-310 of 334) with videos related to

Sort By:
Pageof 34
Journal of the American Society of Nephrology : JASN|December 31, 2005
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease studyEva Boes, Danilo Fliser, Eberhard Ritz, et al.
Cardiovascular Research|February 16, 2012
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular diseaseAndreas Tomaschitz, Eberhard Ritz, Burkert Pieske, et al.
Circulation|August 25, 2010
Homoarginine, cardiovascular risk, and mortalityWinfried März, Andreas Meinitzer, Christiane Drechsler, et al.
Kidney International|March 23, 2012
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockersHiddo J Lambers Heerspink, Frank A Holtkamp, Hans-Henrik Parving, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2011
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysisWinfried März, Bernd Genser, Christiane Drechsler, et al.
European Heart Journal|August 7, 2010
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patientsChristiane Drechsler, Stefan Pilz, Barbara Obermayer-Pietsch, et al.
European Heart Journal|December 6, 2012
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patientsChristiane Drechsler, Eberhard Ritz, Andreas Tomaschitz, et al.
Kidney & Blood Pressure Research|August 19, 2004
Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristicsChristoph Wanner, Vera Krane, Winfried März, et al.
The New England Journal of Medicine|March 11, 2011
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesHermann Haller, Sadayoshi Ito, Joseph L Izzo, et al.
Journal of Hypertension|April 13, 2004
High prevalence and poor control of hypertension in primary care: cross-sectional studyArya M Sharma, Hans-Ulrich Wittchen, Wilhelm Kirch, et al.
Pageof 34